中国实用内科杂志2013，Vol.33Issue(4)：293-295,3.
2012 ESC心脏瓣膜病治疗指南解读及启示
Interpretation and enlightenment of 2012 ESC guideline on the mangement of vavular heart disease
摘要
Abstract
The 2012 edition of valvular heart disease ( VHD) prevention and treatment guideline jointly was issued by the European Society of Cardiology (ESC) and the European Association of Cardiothoracic Surgery (EACTS) in Munich,Germany on the ESC Congress. The guideline update was based on the new clinical evidence collected in the past five years. Major changes include: desalinated the dependence of EuroSCORE and STS score, stressed the importance of establishing the team of heart management for patients, made clear the indications of transcatheter aortic valve implantation ( TAVI) and percutaneous edge-to-edge valve repair,and adjusted the strategy of postoperative anticoagulation. The guideline also suggested us that although interventional treatment of VHD had made considerable progress, sometimes making surgery no longer the only treatment of certain valvular disease, it still had many problems such as choice of indications, management of complications , and follow-up and long-term efficacy evaluation of large-sample, multicenter research. It is not recommended to use this treatment in the big- or medium-sized hospitals whose relevant conditions were not yet mature. For the new clinic technology, we should follow the principles of actively exploring and cautiously advancing.关键词
心脏瓣膜病/指南Key words
valvular heart disease/ guideline分类
医药卫生引用本文复制引用
曾锐,曾智..2012 ESC心脏瓣膜病治疗指南解读及启示[J].中国实用内科杂志,2013,33(4):293-295,3.
